Every day, Mariya Goncheva, PhD, and Corby Fink, PhD, step inside ImPaKT – a world-class bio containment level-3 facility designed specifically to study deadly viruses and bacteria. Protected from head to toe and connected to a positive pressure powered air respirator, they work with live SARS-CoV-2, the virus that causes COVID-19.

Schulich Medicine and Dentistry

 

Robarts Research

class="alignmentRight" style="color: #fff;text-align:right;"> Instagram .Facebook Facebook. Twitter. Youtube

Training infectious disease research leaders

Training infectious disease research leaders

Every day, Mariya Goncheva, PhD, and Corby Fink, PhD, step inside ImPaKT – a world-class bio containment level-3 facility designed specifically to study deadly viruses and bacteria. Protected from head to toe and connected to a positive pressure powered air respirator, they work with live SARS-CoV-2, the virus that causes COVID-19.

Read more

two people holding hands

Promoting research into healthy aging

Alzheimer’s researcher Jane Rylett, PhD, is leading the country’s research efforts around healthy aging and providing opportunities that attend to the complex needs of aging Canadians.

Read more

Neuron

Cough medicine shows promise in treating Parkinson’s disease

An over-the-counter cough medicine may be the key to slowing the progression of Parkinson’s disease.

Read more

brain

Unfolding the hippocampus

A new technique that visually irons out brain wrinkles may provide greater insight on brain disorders.

Read more

Hands typing on laptop with floating graphics of bar graphs and world above

Innovation hub home to new medical technology startup

Pharmasees is a new company located at Robarts; they are creating non-invasive vital monitoring technology with remote and AI capabilities.

Read more

Millions invested in 3D imaging research at Robarts

Millions invested in 3D imaging research at Robarts

Aaron Fenster, PhD, is converting conventional ultrasound machinery into 3D-imaging technology. A world first, it’s inexpensive, non-invasive and non-surgical and provides a comprehensive and accurate diagnostic picture of disease. This research recently received $2.6 million from the Ontario Research Fund.

Read more

Be Extraordinary

Be Extraordinary

Powered by Blackbaud
nonprofit software